GlassScriptPhysician profile
Mary C Maier
NPI 1548234743
$1,362.97
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $80.54 · 2020: $14.81 · 2021: $98.82 · 2022: $269 · 2023: $716 · 2024: $184.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $885 · Education: $15.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $884.69 |
| Education | $15.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $305.78 | 2020-2023 | Nucala, Trelegy Ellipta |
| Abbvie INC. | $252.26 | 2022-2023 | |
| Genzyme Corporation | $247.58 | 2021-2024 | |
| Astrazeneca Pharmaceuticals LP | $141.22 | 2019-2024 | Fasenra, Airsupra |
| Genentech USA, INC. | $69.64 | 2019-2024 | Xolair |
| Takeda Pharmaceuticals U.S.A., INC. | $54.46 | 2023-2024 | Cuvitru, Takhzyro |
| Kaleo, INC. | $53.62 | 2021-2022 | |
| Pfizer INC. | $32.87 | 2023 | |
| Csl Behring | $28.69 | 2024 | Haegarda |
| Shire North American Group INC | $25.81 | 2019 | |
| Amgen INC. | $24.50 | 2024 | Tezspire |
| Blueprint Medicines Corporation | $23.34 | 2023 | Ayvakit |
| Pharming Healthcare, INC. | $20.91 | 2023 | Ruconest |
| Grifols USA, LLC | $20.29 | 2022 | |
| Merck Sharp & Dohme LLC | $18.18 | 2023 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sunovion Pharmaceuticals INC. | $16.84 | 2019 | |
| Biocryst US Sales Co., LLC | $15.14 | 2023 | Orladeyo |
| Genentech, INC. | $11.84 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary Maier listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.